Charles River Laboratories (CRL) — Financial Flexibility Index
Charles River Laboratories (CRL) has a Financial Flexibility Index of 0.06x as of September 2025. Free cash flow of $249.41 Million (operating CF $213.83 Million minus capex $35.58 Million) represents 0% of total liabilities ($4.06 Billion). Also explore CRL net assets growth trend to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Charles River Laboratories Financial Flexibility Index (1998–2024)
Historical Financial Flexibility Index trend for Charles River Laboratories across 27 annual periods. Check how strategically is Charles River Laboratories's equity deployed to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Charles River Laboratories (1998–2024)
Year-by-year free cash flow to debt coverage for Charles River Laboratories. For the full company profile including market capitalisation, see CRL stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.24x | $967.54 Million | $734.58 Million | $4.02 Billion | ▲ +8.9% |
| 2023 | 0.22x | $1.00 Billion | $683.90 Million | $4.54 Billion | ▲ +7.2% |
| 2022 | 0.21x | $944.37 Million | $619.64 Million | $4.58 Billion | ▼ -7.6% |
| 2021 | 0.22x | $989.57 Million | $760.80 Million | $4.43 Billion | ▲ +4.8% |
| 2020 | 0.21x | $713.13 Million | $546.58 Million | $3.35 Billion | ▲ +3.8% |
| 2019 | 0.21x | $621.45 Million | $480.94 Million | $3.03 Billion | ▼ -11.0% |
| 2018 | 0.23x | $581.19 Million | $441.14 Million | $2.52 Billion | ▲ +8.0% |
| 2017 | 0.21x | $398.70 Million | $316.26 Million | $1.87 Billion | ▲ +12.3% |
| 2016 | 0.19x | $353.61 Million | $298.32 Million | $1.86 Billion | ▼ -29.1% |
| 2015 | 0.27x | $349.61 Million | $286.36 Million | $1.30 Billion | ▲ +2.9% |
| 2014 | 0.26x | $307.98 Million | $251.05 Million | $1.18 Billion | ▲ +3.8% |
| 2013 | 0.25x | $246.29 Million | $207.14 Million | $979.96 Million | ▼ -3.3% |
| 2012 | 0.26x | $255.43 Million | $207.90 Million | $983.14 Million | ▲ +5.1% |
| 2011 | 0.25x | $254.43 Million | $205.28 Million | $1.03 Billion | ▲ +21.9% |
| 2010 | 0.20x | $211.87 Million | $169.01 Million | $1.04 Billion | ▼ -44.8% |
| 2009 | 0.37x | $305.06 Million | $225.04 Million | $830.27 Million | ▼ -26.0% |
| 2008 | 0.50x | $477.03 Million | $279.95 Million | $960.47 Million | ▼ -8.5% |
| 2007 | 0.54x | $511.28 Million | $284.25 Million | $941.57 Million | ▲ +49.5% |
| 2006 | 0.36x | $346.12 Million | $164.37 Million | $953.11 Million | ▼ -23.3% |
| 2005 | 0.47x | $332.25 Million | $236.70 Million | $701.48 Million | ▲ +135.5% |
| 2004 | 0.20x | $230.16 Million | $184.83 Million | $1.14 Billion | ▼ -58.3% |
| 2003 | 0.48x | $156.47 Million | $123.77 Million | $324.75 Million | ▼ -8.4% |
| 2002 | 0.53x | $171.20 Million | $133.66 Million | $325.40 Million | ▲ +31.0% |
| 2001 | 0.40x | $107.95 Million | $71.30 Million | $268.86 Million | ▲ +128.2% |
| 2000 | 0.18x | $49.33 Million | $33.77 Million | $280.35 Million | ▲ +64.7% |
| 1999 | 0.11x | $50.52 Million | $37.57 Million | $472.89 Million | ▼ -85.8% |
| 1998 | 0.75x | $49.29 Million | $37.38 Million | $65.69 Million | — |